| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K30748066 |
| PharmacoGx | BRD-K30748066 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TMEM141 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.03 |
| mRNA | RAD51 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.03 |
| mRNA | MFN1 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.03 |
| mRNA | ASAP2 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.03 |
| mRNA | TMED7-TICAM2 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.03 |
| mRNA | EIF3K | CTRPv2 | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | CCT4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.03 |
| mRNA | GLYATL2 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.03 |
| mRNA | LHFPL4 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.03 |
| mRNA | RAD54L2 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.03 |
